We found that trastuzumab treatment induces p53 upregulated modulator of apoptosis (PUMA) expression in GC cells, through the NF‐κB pathway following AKT inhibition and glycogen synthase kinase 3β (GSK3β) activation. This evidence concerns the gene AKT1 and gastric cancer.